CP3 Study

One of the goals identified in the National Psoriasis Foundation's 2020 – 2024 Strategic Plan is to increase the lifespan and health of individuals living with psoriatic disease. Research has shown that people living with psoriatic disease have a reduced life expectancy, which is due to an increased risk of cardiovascular disease (CVD), including heart attack and stroke. [1] Individuals living with psoriatic disease are more likely to have underdiagnosed and undertreated CVD risk factors, such as high blood pressure and high cholesterol. [2]

Funded through NPF's Psoriasis Prevention Initiative, the CP3 study is evaluating the use of an innovative care coordination model in lowering cardiovascular risk in patients with psoriatic disease. Care coordinators meet with enrolled patients living with psoriasis who have an elevated risk of CVD and guide them through their CVD risk calculations, review their risk profile, help develop a diet, exercise, and medication plan, and connect them with a primary care provider.